CME Information

Target Audience

The target audience for this meeting is physicians specializing in the areas of allergy, asthma and immunology.

Statement of Need

Continuing medical education in allergy, asthma and immunology is especially important in light of new therapeutic options that directly target the mechanisms of the immune system. Physicians are increasingly able to offer mechanism-specific pharmacological management to their patients in addition to symptom control. As the allergy, asthma, and immunology armamentarium expands, so does the complexity of therapeutic regimens, necessitating that physician’s be up-to-date on new discoveries as well as established guidelines. This multi-supported initiative will deliver the latest updates and provide practical information on asthma, allergy and immunology topics. Session topics include: indications and contraindications for vaccination, management of food allergies, airway microbiota modulation of inflammatory processes, skin manifestations of allergic diseases, management of contact dermatitis, management of secondary immune deficiency, immune dysregulation and hypersensitivity, emerging technology in the management of allergic disease, and more.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American College of Allergy, Asthma and Immunology and the Western Society for Allergy, Asthma and Immunology.  The American College of Allergy, Asthma and Immunology is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The American College of Allergy, Asthma and Immunology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma and Immunology designates this live activity for AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Program Objectives

 

High Definition, Individualized (Precision, Personalized) Medicine
  • Recognize the current use and value of genomic testing
  • Integrate biosensors into clinical practice
  • Support data sharing and democratization of medicine
Sinonasal Innate Immunity and the Microbiome
  • Describe the role of taste receptors in airway innate defense
  • Recognize how the genetics of bitter taste perception reflects susceptibility to chronic rhinosinusitis and may shape the sinonasal microbiome
  • Incorporate new technologies into the management of post surgical chronic rhinosinusitis patients
Mastering the Food Allergy Diagnosis
  • Select appropriate tests for diagnosing food allergy
  • Interpret tests for diagnosing food allergy
  • Discuss emerging tests to predict severity, threshold and prognosis
What Have We Learned from Aspirin Desensitization in AERD: How Can the Methods be Improved?
  • Employ the currently available methods for aspirin desensitization to improve clinical outcomes in their patients with aspirin sensitivity
  • Evaluate for the possibility of silent desensitization and be able to interpret clinical outcomes
  • Recognize patients who have AERD which have previously been missed
Host Microbe Interactions in the Pathogenesis of Atopic Dermatitis
  • Understand the role of S. aureus and other bacteria in promoting atopic dermatitis
  • Understand the influence of Th2 cytokines on host immune defense
Update on HAE with Normal C1 Inhibitor - Classification, Diagnosis and Management
  • Explain the likely causes of HAE with normal C1 inhibitor 
  • Formulate a diagnostic approach for a patient suspected of having HAE with normal C1 inhibitor
  • Recognize how the treatment of HAE with normal C1 inhibitor differs from the treatment of HAE due to C1INH deficiency
Overview of the Microbiome and its Impact on Inflammatory Disease
  • Describe the typical composition of the human microbiome and the functions that it supplies to the host
  • Summarize evidence that the human microbiome plays a role in inflammatory and allergic diseases
  • Identify mechanisms by which bacteria modulate the immune system
  • Name cutting-edge technologies for exploring microbiome composition, function, and role in disease
Indoor Biomass and Wildfire Smoke Exposure and Human Health
  • To appreciate the impact of indoor biomass and wildfire smoke exposure on human disease
  • Contrast the impact of indoor pollution with ambient air pollution on disease
  • To review potential interventions
Food Allergy and Anaphylaxis
Asthma and Drug Allergy
The Future of Artificial Intelligence in Medicine
  • Recognize the issues of accuracy, misdiagnosis and inefficient workflow in present practice
  • Recognize hte4 use of deep neural networks and algorithms for pattern recognition
  • Identify the risks and benefits of AI in medicine’s future
Drug Allergy/ Hypersensitivity Management: An Examination of Drug Allergies likely to be Encountered by the Practicing Allergist
  • Recognize the types of clinical reactions to Fluoroquinolone antibiotics and be able to distinguish allergic from non-allergic reactions
  • Identify the key features of SDRIFE — “Symmetrical drug-related intertriginous and flexural exanthem” (SDRIFE) and be able to perform the testing necessary to confirm the diagnosis
  • Choose the appropriate challenge tests to manage multiple drug intolerance syndrome
Bacteriotherapy of Atopic Dermatitis. Fallacies, Facts and the Future
  • Effectively manage the use of topical and systemic antibiotics in the treatment of atopic dermatitis
  • Describe current and future trends in the basic and clinical research of atopic dermatitis
The Effect of Air Pollutants on Asthma, Allergic and Immunologic Disease
  • To understand the epidemiology of pollutant-induced airway disease
  • To understand the biological mechanisms by which pollutants impact airway disease
  • To review personal and policy interventions to mitigate pollutant-induced disease
Personalized Approach to Primary Immunodeficiency
  • Describe the newest classification and approach to primary immunodeficiency 
  • Define the utility and use of genetic characterization of primary immunodeficiency
  • Illustrate the benefit of obtaining a specific PI diagnosis
The Harold S. Nelson, MD Lecture: Asthma and Allergic Diseases during Pregnancy
  • Appreciate the data available regarding the safety of asthma and allergy medications during pregnancy
  • Provide optimal management for asthma and other allergic diseases during pregnancy
Post- Surgical Management of CRS: New Technologies
The Intersection of Microbiome, Diet and Inflammatory Disease
  • Summarize how diet influences inflammation in different disease contexts, including airway disease
  • Describe how microbes impact effects of diet directly through the metabolic transformation of dietary components
  • Describe how microbes impact effects of diet indirectly through their effects on signaling pathways
  • Summarize research on dietary intervention as a therapeutic strategy
The Ever-Changing Therapeutic Landscape for HAE due to C1 Inhibitor Deficiency
  • Assess the benefits and limitations of the available treatments for HAE
  • Identify new treatment approaches for HAE that are being developed
  • Organize a comprehensive treatment plan for patients with HAE
Update on Immunoglobulin Therapies and Personalization of Application
  • Define the current options in Ig therapy for patients with PI
  • Use shared decision making in pursuing the best outcome and identify the underlying data justifying the approach
  • Identify current controversies in use application of Ig therapy for patients with PI